Investigations on safety of hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) with Mitomycin C

European Journal of Surgical Oncology

Volumn 32, Issue 10, 2006, Pages 1222-1225

  Schmid, K ^a   Boettcher, M I ^a   Pelz, J O W ^a   Meyer, T ^a   Korinth, G ^a   Angerer, J ^a   Drexler, H ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Hyperthermic intraoperative intraperitoneal chemotherapy; Latex gloves; Mitomycin C; Safety monitoring

Indexed keywords

MITOMYCIN C;

AIR SAMPLING; ANALYTIC METHOD; ARTICLE; CANCER CHEMOTHERAPY; DRUG DETERMINATION; DRUG MONITORING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPERTHERMIC THERAPY; IN VITRO STUDY; OCCUPATIONAL EXPOSURE; OCCUPATIONAL HAZARD; OCCUPATIONAL SAFETY; OPERATING ROOM; PRIORITY JOURNAL; SURGEON; SURGICAL GLOVE; ULTRAVIOLET SPECTROSCOPY;

AIR POLLUTANTS, OCCUPATIONAL; ANTIBIOTICS, ANTINEOPLASTIC; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COMBINED MODALITY THERAPY; GLOVES, PROTECTIVE; HUMANS; HYPERTHERMIA, INDUCED; INTRAOPERATIVE CARE; MEDICAL STAFF, HOSPITAL; MITOMYCIN; OCCUPATIONAL EXPOSURE; OCCUPATIONAL HEALTH; OPERATING ROOMS; PERITONEAL NEOPLASMS;

EID: 33751164441     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejso.2006.05.011     Document Type: Article

References (16)

1. Begossi G., Gonzalez-Moreno S., Ortega-Perez G., Fon L.J., and Sugarbaker P.H. Cytoreduction and intraperitoneal chemotherapy for the management of peritoneal carcinomatosis, sarcomatosis and mesothelioma. EJSO 28 (2002) 80-87
2. Sugarbaker P.H., Mora J.T., Carmignani P., Stuart O.A., and Yoo D. Update on chemotherapeutic agents utilized for perioperative intraperitoneal chemotherapy. Oncologist 10 (2005) 112-122
3. White S.K., Stephens A.D., and Sugarbaker P.H. Hyperthermic intraoperative intraperitoneal chemotherapy safety considerations. AORN J 63 (1996) 716-724
4. Stuart O.A., Stephens A.D., Welch L., and Sugarbaker P.H. Safety monitoring of the coliseum technique for heated intraoperative intraperitoneale chemotherapy with mitomycin C. Ann Surg Oncol 9 2 (2002) 186-191
5. Connor T.H., van Balen P., and Sessink P.J.M. Monitoring for hazardous drugs in the operating room. Ann Surg Oncol 10 7 (2003) 821
6. NIOSH. Polynuclear aromatic hydrocarbons by HPLC. In: Cassinelli M.E., and ÓConnor P.E. (Eds). NIOSH manual of analytical methods (NMAM). 4th ed. (1998), National Institute for Occupational Safety and Health, Washington
7. Franz T.J. Percutaneous absorption on the relevance of in vitro data. J Invest Dermatol 64 3 (1975) 190-195
8. Pethran A., Schierl R., Hauff K., Grimm C.H., Boos K.S., and Nowak D. Uptake of antineoplastic agents in pharmacy and hospital personnel. Part I: monitoring of urinary concentrations. Int Arch Occup Environ Health 76 (2003) 5-10
9. Dranitsaris G., Johnston M., Poirier S., et al. Are health care providers who work with cancer drugs at an increased risk for toxic events? A systematic review and meta-analysis of the literature. J Oncol Pharm Pract 11 (2005) 69-78
10. IARC monographs on the evaluation of carcinogenic risks to humans Vol. 10 (1976), International Agency for Research on Cancer, Lyon, France p. 171
11. Drexler H. Assignment of skin notation for MAK values and its legal consequences in Germany. Int Arch Occup Environ Health 71 (1998) 503-505
12. Jakasa I., Mohammadi N., Kruse J., and Kezic S. Percutaneous absorption of neat and aqueous solutions of 2-butoxyethanol in volunteers. Int Arch Occup Environ Health 77 (2004) 79-84
13. Kiffmeyer T.K., Kube C., Opiolka S., Schmidt K.G., Schöppe G., and Sessink P.J.M. Vapour pressures, evaporation behaviour and airborne concentrations of hazardous drugs: implications for occupational safety. Pharm J 268 (2002) 331-337
14. Connor T.H., Shults M., and Fraser M.P. Determination of the vaporization of solutions of mutagenic antineoplastic agents at 23 and 37 °C using a desiccator technique. Mutat Res 470 (2000) 85-92
15. Connor T.H. Permeability of nitrile rubber, latex, polyurethane, and neoprene gloves to 18 antineoplastic drugs. Am J Health Syst Pharm 56 (1999) 2450-2453
16. van Ruth S., Mathot R.A.A., Sparidans R.W., Beijnen J.H., Verwaal V.J., and Zoetmulder F.A.N. Population pharmacokinetics and pharmacodynamics of mitomycin during intraoperative hyperthermic intraperitoneal chemotherapy. Clin Pharmacokinet 43 (2004) 131-143